Suchergebnisse - "Bernstein, Mallory"

PubPharm (39)

1

HIV status alters disease severity and immune cell responses inβvariant SARS-CoV-2 infection wave

enthalten in: bioRxiv.org | 2024

von Karim, F. | Gazy, I. | Cele, S. | +21

2

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

enthalten in: bioRxiv.org | 2024

von Cele, S. | Gazy, I. | Jackson, L. | +18

3

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

enthalten in: bioRxiv.org | 2024

von Khan, K. | Lustig, G. | Reedoy, K. | +25

4

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

enthalten in: bioRxiv.org | 2024

von Riou, C. | Bhiman, J. | Ganga, Y. | +53

5

Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation

enthalten in: Nature communications | 2024

von Karim, F. | Riou, C. | Bernstein, M. | +28

6

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

enthalten in: PLOS global public health | 2024

von Riou, C. | Bhiman, J. | Ganga, Y. | +53

UpdateOf: medRxiv. 2023 Nov 20;:. - PMID 38045321

7

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations

enthalten in: Virus evolution | 2024

von Lustig, G. | Ganga, Y. | Rodel, H. | +17

8

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant

enthalten in: Nature communications | 2023

von Khan, K. | Lustig, G. | Römer, C. | +26

9

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Riou, C. | Bhiman, J. | Ganga, Y. | +53

UpdateIn: PLOS Glob Public Health. 2024 Apr 11;4(4):e0002703. - PMID 38603677

10

Emergence of neutralizing antibodies associates with clearance of SARS-CoV-2 during HIV-mediated immunosuppression

enthalten in: bioRxiv.org | 2023

von Karim, F. | Bernstein, M. | Jule, Z. | +23